title: Total and unbound lopinavir concentrations in the female genital tract of HIV-1 infected women during pregnancy.
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Else
authors.forename: Fiona
authors.initials: F
authors.lastname: Lyons
authors.forename: Siobhan
authors.initials: S
authors.lastname: O'shea
authors.forename: Sinead
authors.initials: S
authors.lastname: Costello
authors.forename: Jane
authors.initials: J
authors.lastname: Mullen
authors.forename: Martin
authors.initials: M
authors.lastname: Lechelt
authors.forename: Laura
authors.initials: L
authors.lastname: Dickinson
authors.forename: Veronica
authors.initials: V
authors.lastname: Magaya
authors.forename: David J
authors.initials: DJ
authors.lastname: Back
authors.forename: Annemiek
authors.initials: A
authors.lastname: de Ruiter
mesh_terms: D005260:Female; D005836:Genitalia, Female / Q000378:metabolism*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000378:metabolism*; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000378:metabolism*; D011744:Pyrimidinones / Q000378:metabolism*; D017201:Virus Shedding / Q000187:drug effects*
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir